Drug Shortage Report for TEVA-SELEGILINE
Report ID | 103814 |
Drug Identification Number | 02068087 |
Brand name | TEVA-SELEGILINE |
Common or Proper name | SELEGILINE 5MG TABLETS |
Company Name | TEVA CANADA LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | SELEGILINE HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 |
ATC code | N04BD |
ATC description | DOPAMINERGIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-01-20 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-01-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-01-21 | French | Compare |
v1 | 2020-01-21 | English | Compare |
Showing 1 to 2 of 2